AMS BIOTECHNOLOGY (EUROPE) LTD.
History
| Year | Detail |
|---|---|
| 1987 | Founded in 1987, AMSBIO is a life sciences supplier that provides products and services for research and development in the medical, nutrition, cosmetics, and energy industries. |
| 2003 | The company started offering custom services, including monoclonal antibody production, custom protein expression, and polyclonal antibody services. |
| 2011 | AMSBIO acquired the Seikagaku Corp's reagents and glycobiology biochemicals portfolio. |
| 2017 | The company partnered with Dr. Michele Zagoni to launch ScreenIn 3D, a patented lab-on-a-chip technology for screening patient-derived tumor models. |
| 2021 | The company established its offices in the Netherlands to serve European customers after the U.K. left The European Union. |
| 2023 | AMSBIO launched a new extracellular matrix product range for 3D cell culture and PRCC. |
| 2023 | The company acquired cells diagnostics and biotech company Genlantis Inc. |
BCC Research Beacon 